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Abstract
The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients 
and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems 
have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At 
present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To 
ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 
crisis there may be merit in the use of the HaNC-AD PCI.
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The coronavirus disease 2019 (COVID-19) pandemic 
resulted in challenges for clinicians, head and neck can-
cer (HNC) patients and carers that were never previously 
encountered [1]. Some of these challenges are related to 
social distancing and reduced clinical contact. There is evi-
dence that COVID-19 affects the management of patients 
with cancer, [2] but at present we have no effective strategy 
to ensure that cancer patients receive adequate information 
prior to their treatment. Currently there is reduced clinic 
contact and this makes it more difficult to share information 
about cause, stage and treatment outcomes with patients and 
carers. When diagnosed with cancer there is potentially a 
lot of information to take in. Over the years, clinical teams 
perfected ways of ensuring that every patient is adequately 
prepared to face their treatment. During this crisis, surgical 
capacity is being significantly reduced to provide critical 
care facilities as the incidence of COVID-19 increases. Work 
has commenced to prioritise surgical cases. This will have 
a detrimental impact on HNC treatment. Clinicians treating 
HNC patients have to balance the risk in terms of potential 
exposure to COVID-19 during the treatment, inpatient peri-
operative care or outpatient adjuvant treatment. As a conse-
quence of this, patients may have to be prioritised faster and 
reach the definitive treatment day significantly quicker after 
receiving their bad news of their diagnosis. Also, a propor-
tion of patients will be significantly delayed and this will add 
to uncertainty about their care and possible outcome. The 
issue related to a diagnosis of HNC needs to be discussed 
carefully and sensitively. A prompt list can help patients and 
their carers raise any issues which for many reasons under 
the current crisis, fail to disclose before treatment.
The COVID-19 pandemic has introduced extra worries to 
patients with a diagnosis of head and neck cancer. There is 
the risk that during the current crisis, some patients may not 
be prepared emotionally or psychologically to receive life-
changing treatment. This is exacerbated by the required self-
isolation guidance that may have an impact on the availabil-
ity of specific members of the clinical team such as specialist 
nurses, speech and language therapist or dieticians. During 
this crisis, there may be merit in the use of the HaNC-AD 
PCI [3] as a preparation for treatment aid after a diagnosis of 
head and neck cancer and this can be done remotely during 
a telephone consultation.
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In the head and neck oncology setting, the HaNC-AD PCI 
[4] encompasses a comprehensive item prompt list covering 
several broad domains pertinent to patients with a diagnosis 
of cancer to the head and neck (“Appendix 1”). It is based on 
the same principle as the PCI-HNC [5] and in a recent sys-
tematic review [6] and content comparison of unmet needs 
self-report measures favoured the PCI over 13 other tools. 
This is a patient-reported tool, specifically designed for head 
and neck cancer patients, completed by patients following 
diagnosis prior to treatment that can facilitate discussion 
with the wider multi-professional team. It is designed to help 
evoke patient concerns and may be completed by the patient 
at home after the diagnosis. This can then be fully evaluated 
by the clinical team via a follow-up telephone consultation 
prior to treatment. It is very hard to get the amount of infor-
mation right and it needs to be tailored for each individual 
patient especially during this crisis. The information needs 
to be at the ’right’ time for the patient and this can be just 
after the diagnosis.
In our practice following a remote or a face-to-face 
appointment to inform the patient of head and neck can-
cer diagnosis, we give a paper or an electronic copy to the 
patient. Then a member of the treating team contacts the 
patient over the phone 3 days later and discusses any identi-
fied issues. The HaNC-AD PCI gives the opportunity for the 
patient to consider and reflect on aspects of their care within 
a relatively short time frame, allows information exchange 
remotely and gives them the opportunity to assimilate, 
understand the treatment and provide informed consent. This 
simple tool can be given to patients and then be evaluated by 
the clinical nurse specialist prior to the definitive treatment.
Our preliminary experience is that the HaNC-AD PCI 
may provide a very useful tool prior to treatment delivery 
during this crisis, with information delivered remotely by 
the clinical team.
However, more clinical evidence is needed to ensure that 
such a strategy is optimal for head and neck cancer care.
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as used in telephone consultations 
following a diagnosis of head and neck 
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